Sun Pharma#39;s profit, revenue to rise in Q3; EBITDA margin may remain stable

Brokerage firm Motilal Oswal Financial Services expects a 65.7 percent YoY rise in adjusted net profit and a 7.3 percent YoY rise in revenue for the quarter.

from Moneycontrol Latest News https://ift.tt/3j8bvUt